Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study

被引：0
|
作者：
Helen Jenkins
Richard Jenkins
Alain Patat
机构：
[1] Takeda Development Centre Europe Ltd,
[2] Biotrial S.A.,undefined
来源：
Clinical Drug Investigation | 2017年 / 37卷
关键词：
Clarithromycin; Single Oral Dose; Gastric Acid Secretion; Multiple Oral Dose; Potent CYP3A4 Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 316
页数：5
相关论文
共 50 条
  • [41] Pharmacokinetics and Tolerability of Single and Multiple Doses of Ticagrelor in Healthy Chinese SubjectsAn Open-Label, Sequential, Two-Cohort, Single-Centre Study
    Haiyan Li
    Kathleen Butler
    Li Yang
    Zhenghua Yang
    Renli Teng
    Clinical Drug Investigation, 2012, 32 : 87 - 97
  • [42] Pharmacokinetics and Tolerability of Single and Multiple Doses of Ticagrelor in Healthy Chinese Subjects An Open-Label, Sequential, Two-Cohort, Single-Centre Study
    Li, Haiyan
    Butler, Kathleen
    Yang, Li
    Yang, Zhenghua
    Teng, Renli
    CLINICAL DRUG INVESTIGATION, 2012, 32 (02) : 87 - 97
  • [43] A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
    Evens, Andrew M.
    Balasubramanian, Sriram
    Vose, Julie M.
    Harb, Wael
    Gordon, Leo I.
    Langdon, Robert
    Sprague, Julian
    Sirisawad, Mint
    Mani, Chitra
    Yue, Jeanne
    Luan, Ying
    Horton, Sharon
    Graef, Thorsten
    Bartlett, Nancy L.
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1059 - 1066
  • [44] Pharmacokinetic properties of isradipine after single-dose and multiple-dose oral administration in Chinese volunteers: a randomized, open-label, parallel-group phase I study
    Wang, Yanran
    Jin, Zhaohui
    Wang, Zhijun
    Jiang, Xuehua
    Wang, Ling
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (12) : 1664 - 1670
  • [45] Pharmacokinetic Interaction of Chiglitazar With CYP3A4 Inducer or Inhibitor: An Open-Label, Sequential Crossover, Self-Control, 3-Period Study in Healthy Chinese Volunteers
    Yuan, Fei
    Li, Jing
    Li, Xuening
    Li, Hui
    Chen, Weili
    Yang, Mengjie
    Chen, Hanjing
    Sheng, Lei
    Liu, Chao
    Wu, Yujia
    Xu, Hongrong
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (02): : 168 - 174
  • [46] Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans
    Ma, Sheng
    Yi, Ling
    Bian, Yicong
    Lv, Binhua
    Zhang, Cong
    Li, Chengwei
    Zhang, Hua
    Miao, Liyan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [47] Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers
    Cohen, Fredric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 87 - 94
  • [48] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S80 - S80
  • [49] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S31 - S31
  • [50] A Phase I, Open-Label PET Study of the Pharmacokinetics, Tolerability and D2/D3 Striatal Occupancy of Single- Dose Oral OPC-34712 in Healthy Subjects
    Wong, Dean F.
    Malikaarjun, Suresh
    Raofinia, Arash
    Bricmont, Patricia
    Brasic, James
    McQuade, Robert D.
    Forbes, Robert A.
    Carson, William H.
    Kikuchi, Tetsuro
    Willis, William
    Kuwabara, Hiroto
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 187S - 187S
12345